Published in:
01-07-2015 | Editorial
Mesenchymal Stem Cells in IBD: unMaSCing Their Therapeutic Mechanisms
Published in: Digestive Diseases and Sciences | Issue 7/2015
Login to get accessExcerpt
Given the ethical concerns surrounding the procurement of embryonic stem cells, the study of adult stem cells has become increasingly attractive. In particular, the interest in the growing therapeutic potential of mesenchymal stem cells (MSCs) over the last decade is reflected by the more than 400 clinical trials registered on clinicaltrials.gov and the >30,000 scientific publications addressing this subject, which are increasing at a rate of 1200/year (Fig. 1). Despite this extraordinarily rapid growth of knowledge, the effective mechanisms underlying the therapeutic activities of MSCs have not been fully elucidated.
Fig. 1
Number of publications related to MSCs recorded in PubMed per year
× ![]()
…